Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, signaling a new deployment of the page; this is a system-level update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:33:14.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small template or system update for the study page.
    Difference
    0.1%
    Check dated 2026-08-10T12:20:49.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a minor update to the study page metadata without changing its content.
    Difference
    0.1%
    Check dated 2026-07-27T06:23:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Footer now includes references to the Moffitt Clinical Trials website and sponsor organization, plus a 'Helpful Links Provided by' attribution. The revision tag has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T12:25:32.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2. This indicates a newer page build without changes to the study content or data.
    Difference
    0.1%
    Check dated 2026-06-28T08:48:49.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', and new help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to assist users. The Intervention/Treatment header was reformatted to 'Intervention / Treatment' and the revision label updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-14T00:23:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.